FIELD: medicine, oncology, pharmacy. SUBSTANCE: invention relates to medicinal agents showing an antitumor effect. Invention proposes a selenium-base agent made as 1.0-2.5% an aqueous- spirituous solution comprising di-(3-methylpyrazolyl-4)-selenide as an active substance taken in concentration 0.04-0.08%. EFFECT: enhanced therapeutic effect, decreased toxicity. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION SHOWING ANTITUMOR EFFECT | 1995 |
|
RU2094047C1 |
METHOD FOR PREVENTING OBSTETRIC-GYNECOLOGICAL DISEASES IN SOWS AND INCREASING VIABILITY IN PIGLETS | 2004 |
|
RU2260426C1 |
METHOD FOR PREVENTING MALIGNANT PROCESS DEVELOPMENT EXPERIMENTALLY | 2014 |
|
RU2559086C1 |
11-DESOXY-17ALPHA-OXY-21-/H-DI(2-CHLORETHYL) AMINOPHENYLACETATE/-CORTICOSTERONE SHOWING ANTITUMOR ACTIVITY | 0 |
|
SU1249022A1 |
PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
POLYMER CONTAINING MEDICINAL AGENT BASED ON ANTITUMOR AGENT ETOPOSIDE | 2015 |
|
RU2595859C1 |
AGENT FOR PROPHYLAXIS DISEASES OF ONCOLOGICAL AND NON-ONCOLOGICAL PATTERN AND FOR CORRECTION OF HOMEOSTASIS DISTURBANCES | 2001 |
|
RU2208446C2 |
METHOD OF TREATMENT BREAST CANCER | 2008 |
|
RU2393888C1 |
METHOD FOR PROPHYLACTIC TREATMENT IN CASE OFNEOPLASTIC PROCESSES INVOLVING SKIN TISSUE, SUCH AS MELANOMA, BASAL CELL AND SQUAMOUS CELL CARCINOMA | 2015 |
|
RU2619208C2 |
APPLICATION OF 9-OCOACRIDINE-10-ACETIC ACID AND/OR ITS SALT COMBINED WITH ANTIESTROGEN AND/OR PROGESTIN FOR TREATMENT OF STROGEN-DEPENDENT TUMOURS, METHOD OF TREATMENT AND SETS | 2007 |
|
RU2346691C2 |
Authors
Dates
2002-07-27—Published
2001-10-18—Filed